Just - Evotec Biologics
Teresa L. Born, PhD has worked in various scientific and leadership roles in biotechnology companies such as Just - Evotec Biologics, Allen Institute for Cell Science, Sartorius Stedim BioOutsource, and Amgen. She has extensive experience in biosimilar program development, bioanalytical testing, biological characterization, and inflammation therapeutic research. Teresa has a strong background in molecular genetics and biomedical sciences, with a proven track record of success in leading scientific teams and programs.
Just - Evotec Biologics
1 followers
Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com